Congenital myasthenic syndromes: A diverse array of molecular targets

Journal of Neurocytology

Volumn 32, Issue 5-8, 2003, Pages 1017-1037

  Engel, Andrew G ^a   Ohno, Kinji ^a   Sine, Steven M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CHOLINE ACETYLTRANSFERASE; CHOLINERGIC RECEPTOR; RAPSYN; SODIUM CHANNEL;

EATON LAMBERT SYNDROME; ENZYME DEFICIENCY; ENZYME SUBUNIT; GENE MUTATION; HUMAN; IMMUNOCYTOCHEMISTRY; MOLECULAR DYNAMICS; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFECT; PROTEIN EXPRESSION; REVIEW; SYNAPTIC TRANSMISSION; ANIMAL; CHEMISTRY; CONGENITAL MYASTHENIC SYNDROME; GENETICS; METABOLISM; METHODOLOGY; MUTATION; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

ANIMALS; CHOLINE O-ACETYLTRANSFERASE; DNA MUTATIONAL ANALYSIS; HUMANS; MUTATION; MYASTHENIC SYNDROMES, CONGENITAL; RECEPTORS, CHOLINERGIC;

EID: 3042617450     PISSN: 03004864     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEUR.0000020639.22895.28     Document Type: Review

References (132)

1. ABICHT, A., STUCKA, R., KARCAGI, V. et al. (1999) A common mutation (ε1267delG) in congenital myasthenic patients of Gypsy ethnic origin. Neurology 53, 1564-1569.
2. ABICHT, A., STUCKA, R., SCHMIDT, C et al. (2002) A newly identified chromosomal microdeletion and an N-box mutation of the AChRε gene cause a congenital myasthenic syndrome. Brain 125, 1005-1013.
3. ADAMS, M. E., KRAMARCY, M., KRALL, S. P. et al. (2000) Absence of α-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin. J. Cell Biol. 150, 1385-1398.
4. ALTIOK, N., ALTIOK, K. & CHANGEUX, J.-P. (1997) Heregulin-stimulated acetylcholine receptor gene expression in muscle - requirement for MAP kinase and evidence for parallel inhibitory pathway independent electrical activity. EMBO J. 16, 717-725.
5. APEL, E. D., GLASS, D. J., MOSCOSCO, L. M., YANCOPOULOS, G. D. & SANES, J. R. (1997) Rapsyn is required for MuSK signaling and recruits synaptic components to a MuSK-containing scaffold. Neuron 18, 623-625.
6. APPARSUNDARAM, S., FERGUSON, S. M., GEORGE, A. L. JR. & BLAKELY, R. D. (2000) Molecular cloning of a human, hemicholinium-3-sensitive choline transporter. Biochemical and Biophysical Research Communications 276, 862-867.
7. ARIKAWA-HIRASAWA, E., ROSSI, S. G., ROTUNDO, R. L. & YAMADA, Y. (2002) Absence of acetylcholinesterase at the neuromuscular junction of perlecannull mice. Nature Neurosci. 5, 119-123.
8. BARTOLI, M. & COHEN, J. B. (2001) Identification of the modular domains of rapsyn binding to nicotinic acetylcholine receptor (AChR) and to dystroglycan. Society for Neurosciennce Abstracts 27, Program No. 904.16 (abstract).
9. BARTOLI, M., RAMARAO, M. K. & COHEN, J. B. (2001) Interactions of the rapsyn RING-H2 domain with dystroglycan. Journal of Biological Chemistry 276, 24911-24917.
10. BEESON, D., BRYDSON, M., BETTY, M. et al. (1993) Primary structure of the human muscle acetylcholine receptor: cDNA cloning of the gamma and epsilon subunits. European Journal of Biochemistry 215, 229-238.
11. BEESON, D., BRYDSON, M. & NEWSOM-DAVIS, J. (1989) Nucleotide sequence of human muscle acetylcholine receptor beta subunit. Nucleic Acids Research 17, 4391.
12. BELLUARDO, N., WESTERBLAD, H., MUDO, G. et al. (2001) Neuromuscular junction disassembly and muscle fatigue in mice lacking neurotrophin-4. Moll. Cell. Neurosci. 18, 56-67.
13. BON, S., COUSSEN, F. & MASSOULIÉ, J. (1997) Quaternary associations of acetylcholinesterase. II. The polyproline attachment domain of the collagen tail. Journal of Biological Chemistry 272, 3016-3021.
14. BREJC, K., VAN DIJK, W. V., SCHUURMANS, M., VAN DER OOST, J., SMIT, A. B. & SIXMA, T. K. (2001) Crystal structure of ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411, 269-276.
15. BRENGMAN, J. M., SHAPIRA, Y. A., SADEH, M., TSUJINO, A., OHNO, K. & ENGEL, A. G. (2001) Neomutations in the collagenic tail subunit (ColQ) of acetylcholinesterase. Neurology 56(Suppl.3), A60-A61 (abstract).
16. BROWNLOW, S., WEBSTER, R., CROXEN, R. et al. (2001) Acetylcholine receptor δ subunit mutations underlie a fast-channel myasthenic syndrome and arthrogryposis multiplex congenita. Journal of Clinical Investigation 108, 125-130.
17. BUCKEL, A., BEESON, D., JAMES, M. & VINCENT, A. (1996) Cloning of the cDNA encoding human rapsyn and mapping the RAPSN gene locus to chromosome 11p11.2-p11.1. Genomics 35, 613-616.
18. BURGESS, R. W., NGUYEN, Q. T., SON, Y. J., LICHTMAN, J. W. & SANES, J. R. (1999) Alternatively spliced isoforms of nerve- and muscle-derived agrin: Their roles at the neuromuscular junction. Neuron 23, 33-44.
19. BYRING, R. F., PIHKO, H., SHEN, X.-M. et al. (2002) Congenital myasthenic syndrome associated with episodic apnea and sudden infant death. Neuromuscular Disorders 12, 548-553.
20. CARTAUD, A., COUTANT, S., PETRUCCI, T. C. & CARTAUD, J. (1998) Evidence for in situ and in vitro association between β-dystroglycan and the subsynaptic 43 K rapsyn protein. Consequence for acetylcholine receptor clustering at the synapse. Journal of Biological Chemistry 273, 11321-11326.
21. CROXEN, R., HATTON, C., SHELLEY, C. et al. (2002a) Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes. Neurology 59, 162-168.
22. CROXEN, R., NEWLAND, C., BEESON, D. et al. (1997) Mutations in different functional domains of the human muscle acetylcholine receptor α subunit in patients with the slow-channel congenital myasthenic syndrome. Human Molecular Genetics 6, 767-774.
23. CROXEN, R., NEWLAND, C., BETTY, M., VINCENT, A., NEWSOM-DAVIS, J. & BEESON, D. (1999) Novel functional ε-subunit polypeptide generated by a single nucleotide deletion in acetylcholine receptor deficiency congenital myasthenic syndrome. Annals of Neurology 46, 639-647.
24. CROXEN, R., VINCENT, A., NEWSOM-DAVIS, J. & BEESON, D. (2002b) Myasthenia gravis in a woman with congenital AChR deficiency due to epsilon-subunit mutation. Neurology 58, 1563-1565.
25. CROXEN, R., YOUNG, C., SLATER, C. et al. (2001) End-plate γ- and ε subunit mRNA levels in AChR deficiency syndrome due to ε subunit null mutations. Brain 124, 1362-1372.
26. DEPREZ, P. N. & INESTROSA, N. C. (1995) Two heparin-binding domains are present on the collagenic tail of asymmetric acetylcholinesterase. Journal of Biological Chemistry 270, 11043-11046.
27. DONGER, C., KREJCI, E., SERRADELL, P. et al. (1998) Mutation in the human acetylcholinesterase-associated gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency. American Journal of Human Genetics 63, 967-975.
28. DUCLERT, A., SAVATIER, N., SCHAEFEER, L. & CHANGEUX, J.-P. (1996) Identification of an element crucial for the sub-synaptic expression of the acetylcholine receptor epsilon-subunit gene. Journal of Biological Chemistry 271, 17433-17438.
29. EALING, J., WEBSTER, R., BROWNLOW, S. et al. (2002) Mutations in congenital myasthenic syndromes reveal an ε subunit C-terminal cysteine, C470, crucial for maturation and surface expressions of adult AChR. Human Molecular Genetics 11, 3087-3096.
30. EIDEN, L. E. (1998) The cholinergic gene locus. Journal of Neurochemistry 70, 2227-2240.
31. ENGEL, A. G. (1993) The investigation of congenital myasthenic syndromes. Ann. N. Y. Acad. Sci. 681, 425-434.
32. ENGEL, A. G., LAMBERT, E. H. & GOMEZ, M. R. (1977) A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release. Annals of Neurology 1, 315-330.
33. ENGEL, A. G., LAMBERT, E. H., MULDER, D. M. et al. (1982) A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel. Annals of Neurology 11, 553-569.
34. ENGEL, A. G., OHNO, K., BOUZAT, C., SINE, S. M. & GRIGGS, R. G. (1996a) End-plate acetylcholine receptor deficiency due to nonsense mutations in the ε subunit. Annals of Neurology 40, 810-817.
35. ENGEL, A. G., OHNO, K., MILONE, M. et al. (1996b) New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Human Molecular Genetics 5, 1217-1227.
36. ENGEL, A. G., OHNO, K. & SINE, S. M. (1999) Congenital myasthenic syndromes. In Myasthenia Gravis and Myasthenic Disorders (edited by ENGEL, A. G.) pp. 251-297. New York: Oxford University Press.
37. ERICKSON, J. D., VAROQUI, H., EIDEN, L. E. et al. (1994) Functional identification of a vesicular acetylcholine transporter and its expression from a 'cholinergic' gene locus. Journal of Biological Chemistry 269, 21929-21932.
38. + channels and ankyrin in neuromuscular junctions is complementary to that of acetylcholine receptors and the 43 kd protein. Neuron 3, 163-175.
39. FROEHNER, S. C., LUETJE, C. W., SCOTLAND, P. B. & PATRICK, J. (1990) The postsynaptic 43 K protein clusters muscle nicotinic acetylcholine receptors in Xenopus oocytes. Neuron 5, 403-410.
40. FROMM, L. & BURDEN, S. J. (1998) Synapse-specific and neuregulin-induced transcription require an Ets site that binds CABPα/GAPBβ. Genes and Development 12, 3074-3083.
41. FUKUDOME, T., OHNO, K., BRENGMAN, J. M. & ENGEL, A. G. (1998) Quinidine normalizes the open duration of slow-channel mutants of the acetylcholine receptor. Neuroreport 9, 1907-1911.
42. GAUTAM, M., NOAKES, P. G., MOSCOSO, L. et al. (1996) Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 85, 525-535.
43. GAUTAM, M., NOAKES, P. G., MUDD, J. et al. (1995) Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice. Nature 377, 232-236.
44. GLASS, D. J., BOWEN, D. C., STITT, T. N. et al (1996) Agrin acts via MuSK receptor complex. Cell 85, 513-523.
45. GOMEZ, C. M., MASELLI, R., GAMMACK, J. et al. (1996) A beta-subunit mutation in the acetylcholine receptor gate causes severe slow-channel syndrome. Annals of Neurology 39, 712-723.
46. GOMEZ, C. M., MASELLI, R., STAUB, J. et al. (1998) Novel δ and β subunit acetylcholine receptor mutations in the slow-channel syndrome demonstrate phenotypic variability. Society for Neurosciennce Abstracts 24, 484 (abstract).
47. GOMEZ, C. M., MASELLI, R., VOHRA, B. P. S. et al. (2002) Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanism. Annals of Neurology 51, 102-112.
48. GONZALES, M., RUGGIERO, F. P., CHANG, Q. et al. (1999) Disruption of Trkb-mediated signaling induces disassembly of postsynaptic receptor clusters at neuromuscular junctions. Neuron 24, 567-583.
49. GRADY, R. M., MERLIE, J. P. & SANES, J. R. (1997) Subtle neuromuscular defects in utrophin-deficient mice. Journal of Cell Biology 136, 871-882.
50. GREER, M. & SCHOTLAND, M. (1960) Myasthenia gravis in the newborn. Pediatrics 26, 101-108.
51. HARPER, C. M. & ENGEL, A. G. (1998) Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome. Annals of Neurology 43, 480-484.
52. HARPER, C. M., FUKUDOME, T. & ENGEL, A. G. (2003) Treatment of slow channel congenital myasthenic syndrome with fluoxetine. Neurology 60, 170-173.
53. HUTCHINSON, D. O., WALLS, T. J., NAKANO, S. et al. (1993) Congenital endplate acetylcholinesterase deficiency. Brain 116, 633-653.
54. ISHIGAKI, K., NICOLLE, D., KREJCI, E. et al. (2003) Two novel mutations in the COLQ gene causing endplate acetylcholinesterase deficiency. Neuromuscular Disorders 13, 236-244.
55. JONES, S. F. & KWANBUNBUMPEN, S. (1970) Some effects of nerve stimulation and hemicholinium on quantal transmitter release at the mammalian neuromuscular junction. Journal of Physiology (London) 207, 51-61.
56. KATZ, B. (1996) Nerve, Muscle, and Synapse. New York: McGraw-Hill.
57. KATZ, B. & MILEDI, R. (1973) The binding of acetylcholine to receptors and its removal from the synaptic cleft. Journal of Physiology (London) 231, 549-574.
58. KATZ, B. & THESLEFF, S. (1957) A study of the 'desensitization' produced by acetylcholine at the motor end-plate. Journal of Physiology (London) 138, 63-80.
59. KIMBELL, L. M., OHNO, K., ROTUNDO, R. L. & ENGEL, A. G. (2001) C-terminal and heparin-binding domains of Col Q are both essential for anchoring acetylcholinesterase at the synapse. J. Biol. Chem. In press.
60. KREJCI, E., COUSSEN, F., DUVAL, N. et al. (1991) Primary structure of a collagenic tail peptide of Torpedo acetylcholinesterase: Co-expression with catalytic subunit induces the production of collagen-tailed forms in transfected cells. EMBO Journal 10, 1285-1293.
61. KREJCI, E., THOMINE, S., BOSCHETTI, N., LEGAY, C., SKETELJ, J. & MASSOULIÉ, J. (1997) The mammalian gene of acetylcholinesterase- associated collagen. Journal of Biological Chemistry 272, 22840-22847.
62. LEE, Y. I., SWOPE, S. L. & FERNS, M. J. (2002) Rapsyn's C-terminal domain mediates MuSK-induced phosphorylation of the AChR. Mol. Biol. Cell 13, 395a (abstract).
63. LEGAY, C., STROCHLIC, L., LAMBERGEON, M., BLANCHARD, B., CARTAUD, A. & CARTAUD, J. (2002) Collagen-tailed forms of acetylcholinesterase are anchored to the basal lamina by a dual mechanism involving perlecan and MuSK. Molec. Biol. Cell 13, 394a-395a (abstract).
64. MAIMONE, M. M. & ENIGK, R. E. (1999) The intracellular domain of the nicotinic acetylcholine receptor a subunit mediates its coclustering with rapsyn. Molec. Cell Neurosci. 14, 340-354.
65. MAIMONE, M. M. & MERLIE, J. P. (1993) Interaction of the 43 kd postsynaptic protein with all subunits of the muscle nicotinic acetylcholine receptor. Neuron 11, 53-66.
66. MARCHAND, S., BIGNAMI, F., STETZKOWSKI-MARDEN, F. & CARTAUD, J. (2000) The myristoylated protein rapsyn is cotargeted with the nicotinic acetylcholine receptor to the postsynaptic membrane via the exocytic pathway. Journal of Neuroscience 20, 521-528.
67. MARCHAND, S., DEVILLERS-THIÉRY, A., PONS, S., CHANGEUX, J.-P. & CARTAUD, J. (2002) Rapsyn escorts the nicotinic acetylcholine receptor along the exocytic pathway via association with lipid rafts. Journal of Neuroscience 22, 8891-8901.
68. MARTIN, A. R. (1994) Amplification of neuromuscular transmission by postjunctional folds. Proc R Soc Lond [Biol] 258, 321-326.
69. MASELLI, R. A., CHEN, D., DELORES, M. O., BOWE, C., FENTON, G. & WOLLMAN, R. L. (2003) Choline acetyltransferase mutations in myasthenic syndrome due to deficient acetycholine resynthesis. Muscle and Nerve 27, 180-187.
70. MASELLI, R. A. & SOLIVEN, B. C. (1991) Analysis of the organophosphate-induced electromyographic response to repetitive nerve stimulation: Paradoxical response to edrophonium and d-tubocurarine. Muscle and Nerve 14, 1182-1188.
71. MASSOULIE, J., ANSELMET, A., BON, S. et al. (1999) The polymorphism of acetylcholinesterase: Posttranslational processing, quaternary associations and localization. Chem. Biol. Interact. 119-120, 29-42.
72. MASSOULIÉ, J., PEZZEMENTI, L., BON, S., KREJCI, E. & VALETTE, F.-M. (1993) Molecular and cellular biology of cholinesterases. Progresss in Neurobiology 41, 31-91.
73. MAULET, Y., CAMP, S., GIBNEY, G., RACHINSKY, T. L., EKSTROM, T. J. & TAYLOR, P. (1990) A single gene encodes glycophospholipid-anchored and asymmetric acetylcholinesterase forms: Alternative coding exons contain inverted repeat sequences. Neuron 4, 289-301.
74. MIDDLETON, L., OHNO, K., CHRISTODOULOU, K. et al. (1999) Congenital myasthenic syndromes linked to chromosome 17p are caused by defects in acetylcholine receptor ε subunit gene. Neurology 53, 1076-1082.
75. MILONE, M., HUTCHINSON, D. O. & ENGEL, A. G. (1994) Patch-clamp analysis of the properties of acetylcholine receptor channels at the normal human endplate. Muscle and Nerve 17, 1364-1369.
76. MILONE, M., WANG, H.-L., OHNO, K. et al. (1997) Slow-channel syndrome caused by enhanced activation, desensitization, and agonist binding affinity due to mutation in the M2 domain of the acetylcholine receptor alpha subunit. Journal of Neuroscience 17, 5651-5665.
77. MILONE, M., WANG, H.-L., OHNO, K. et al. (1998) Mode switching kinetics produced by a naturally occurring mutation in the cytoplasmic loop of the human acetylcholine receptor ε subunit. Neuron 20, 575-588.
78. MORA, M., LAMBERT, E. H. & ENGEL, A. G. (1987) Synaptic vesicle abnormality in familial infantile myasthenia. Neurology 37, 206-214.
79. NEWEY, S. A., GRAMOLINI, A. O., WU, J. et al. (2001) A novel mechanism for modulating synaptic gene expression: Differential localization of α-dystrobrevin transcripts in skeletal muscle. Mol. Cell Neurosci. 17, 127-140.
80. NICHOLS, P. R., CROXEN, R., VINCENT, A. et al. (1999) Mutation of the acetylcholine receptor ε-subunit promoter in congenital myasthenic syndrome. Annals of Neurology 45, 439-443.
81. NODA, M., FURUTANI, Y., TAKAHASHI, H. et al. (1983) Cloning and sequence analysis of calf cDNA and human genomic DNA encoding alpha-subunit precursor of muscle acetylcholine receptor. Nature 305, 818-823.
82. ODA, Y., NAKANISHI, I. & DEGUCHI, T. (1992) A complementary DNA for human choline acetyltransferase induces two forms of enzyme with different molecular weights in cultured cells. Brain Research. Molecular Brain Research 16, 287-294.
83. OHNO, K., ANLAR, B. & ENGEL, A. G. (1999a) Congenital myasthenic syndrome caused by a mutation in the Ets-binding site of the promoter region of the acetylcholine receptor ε subunit gene. Neuromuscular Disorders 9, 131-135.
84. OHNO, K., ANLAR, B., ÖZDIRIM, E., BRENGMAN, J. M., DE BLEECKER, J. L. & ENGEL, A. G. (1998a) Myasthenic syndromes in Turkish kinships due to mutations in the acetylcholine receptor. Annals of Neurology 44, 234-241.
85. OHNO, K., BRENGMAN, J. M., FELICE, K. J., CORNBLATH, D. R. & ENGEL, A. G. (1999b) Congenital endplate acetylcholinesterase deficiency caused by a nonsense mutation and an A-to-G splice site mutation at position +3 of the collagen-like tail subunit gene (COLQ): How does G at position +3 result in aberrant splicing? American Journal of Human Genetics 65, 635-644.
86. OHNO, K., BRENGMAN, J. M., TSUJINO, A. & ENGEL, A. G. (1998b) Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme. Proc. Natl. Acad. Sci. USA 95, 9654-9659.
87. OHNO, K. & ENGEL, A. G. (2004) Congenital myasthenic syndromes: Gene mutations. Neuromuscular Disorders 14, 117-122.
88. OHNO, K., ENGEL, A. G., BRENGMAN, J. M. et al. (2000a) The spectrum of mutations causing endplate acetylcholinesterase deficiency. Annals of Neurology 47, 162-170.
89. OHNO, K., ENGEL, A. G., SHEN, X.-M. et al. (2002) Rapsyn mutations in humans cause endplate acetylcholine receptor deficiency and myasthenic syndrome. American Journal of Human Genetics 70, 875-885.
90. OHNO, K., HUTCHINSON, D. O., MILONE, M. et al. (1995) Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the ε subunit. Proceedings of the National Academy of Sciences of the United States of America 92, 758-762.
91. OHNO, K., MILONE, M., BRENGMAN, J. M. et al. (1998c) Slow-channel congenital myasthenic syndrome caused by a novel mutation in the acetylcholine receptor ε subunit. Neurology 50, A432 (abstract).
92. OHNO, K., QUIRAM, P., MILONE, M. et al. (1997) Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor ε subunit gene: Identification and functional characterization of six new mutations. Human Molecular Genetics 6, 753-766.
93. OHNO, K., SADEH, M., BLATT, I., BRENGMAN, J. M. & ENGEL, A. G. (2003) E-box mutations in RAPSN promoter region in eight cases with congenital myasthenic syndrome. Human Molecular Genetics 12, 739-748.
94. OHNO, K., TSUJINO, A., BRENGMAN, J. M. et al. (2001) Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc. Natl. Acad. Sci. USA 98, 2017-2022.
95. OHNO, K., WANG, H.-L., MILONE, M. et al. (1996) Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor ε subunit. Neuron 17, 157-170.
96. OHNO, K., WANG, H.-L., SHEN, X.-M. et al. (2000b) Slow-channel mutations in the center of the M1 transmembrane domain of the acetylcholine receptor α subunit. Neurology 54(Suppl 3), A183 (abstract).
97. OKUDA, T., HAGA, T., KANAI, Y., ENDOU, H., ISHIHARA, T. & KATSURA, I. (2000) Identification and characterization of the high-affinity choline transporter. Nature Neurosci. 3, 120-125.
98. PROCKOP, D. J. & KIVIRIKKO, K. I. (1995) Collagens: Molecular biology, diseases, and potentials for therapy. Annual Review of Biochemistry 64, 403-434.
99. QUIRAM, P., OHNO, K., MILONE, M. et al. (1999) Mutation causing congenital myasthenia reveals acetylcholine receptor β/δ subunit interaction essential for assembly. Journal of Clinical Investigation 104, 1403-1410.
100. RAMARAO, M. K., BIANCHETTA, M. J., LANKEN, J. & COHEN, J. B. (2001) Role of rapsyn tetratrichopeptide repeat and coiled-coil domains in self-association and nicotinic acetylcholine receptor clustering. Journal of Biological Chemistry 276, 7475-7483.
101. RAMARAO, M. K. & COHEN, J. B. (1998) Mechanism of nicotinic acetylcholine receptor cluster formation by rapsyn. Proc. Natl. Acad. Sci. USA 95, 4007-4012.
102. REIMER, R. J., FON, A. E. & EDWARDS, R. H. (1998) Vesicular neurotransmitter transport and the presynaptic regulation of quantal size. Current Opinion in Neurobiology 8, 405-412.
103. RUFF, R. L. (1996) Sodium channel slow inactivation and the distribution of sodium channels on skeletal muscle fibres enable the performance properties of different skeletal muscle fiber types. Acta Physiol. Scand. 156, 159-168.
104. SALPETER, M. M. (1987) Vertebrate neuromuscular junctions: General morphology, molecular organization, and functional consequences. In The Vertebrate Neuromuscular Junction (edited by SALPETER, M. M.) pp. 1-54. New York: Alan Liss.
105. SALPETER, M. M., KASPRZAK, H., FENG, H. & FERTUCK, H. (1979) End-plates after esterase inactivation in vivo: Correlation between esterase concentration, functional response and fine structure. Journal of Neurocytology 8, 95-115.
106. SANDROCK, A. W., DRYER, S. E., ROSEN, K. M. et al. (1997) Maintenance of acetylcholine receptor number by neuregulins at the neuromuscular junction in vivo. Science 276, 599-603.
107. SCHAEFFER, L., DUCLERT, N., HUCHET-DYMANUS, M. & CHANGEUX, J.-P. (1998) Implication of a multisubunit Ets-related transcription factor in synaptic expression of the nicotinic acetylcholine receptor. EMBO J. 17, 3078-3090.
108. SCHMIDT, C., ABICHT, A., KRAMPFL, K. et al. (2003) Congenital myasthenic syndrome due to a novel missense mutation in the gene encoding choline acetyltransferase. Neuromuscular Disorders 13, 245-251.
109. SCHOEPFER, R., LUTHER, M. A. & LINDSTROM, J. (1988) The human medulloblastoma cell line TE671 expresses a muscle-like acetylcholine receptor. Cloning of the alpha-subunit cDNA. FEBS Letters 226, 235-240.
110. SHAPIRA, Y. A., SADEH, M. E., BERGTRAUM, M. P. et al. (2002) Three novel COLQ mutations and variation of phenotypic expressivity due to G240X. Neurology 58, 603-609.
111. SHEN, X.-M., OHNO, K., FUKUDOME, T. et al. (2002) Congenital myasthenic syndrome caused by low-expressor fast-channel AChR δ subunit mutation. Neurology 59, 1881-1888.
112. SHEN, X.-M., OHNO, K., TSUJINO, A. et al. (2003) Mutation causing severe myasthenia reveals functional asymmetry of AChR signature Cys-loops in agonist binding and gating. Journal of Clinical Investigation 111, 497-505.
113. SI, J., LUO, Z. & MEI, L. (1996) Induction of acetylcholine receptor gene expression by ARIA requires activation of mitogen-activated protein kinase. Journal of Biological Chemistry 271, 19752-19759.
114. SIEB, J. P., MILONE, M. & ENGEL, A. G. (1996) Effects of the quinoline derivatives quinine, quinidine, and chloroquine on neuromuscular transmission. Brain Research 712, 179-189.
115. SINE, S. M. (2002) The nicotinic receptor binding domain. Journal of Neurobiology 53, 431-446.
116. SINE, S. M., OHNO, K., BOUZAT, C. et al. (1995) Mutation of the acetylcholine receptor α subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron 15, 229-239.
117. SINE, S. M., SHEN, X.-M., WANG, H.-L. et al. (2002a) Naturally occurring mutations at the acetylcholine receptor binding site independently alter ACh binding and channel gating. Journal of General Physiology 120, 483-496.
118. SINE, S. M., WANG, H.-L. & BREN, N. (2002b) Lysine scanning mutagenesis delineates structure of nicotinic receptor binding domain. Journal of Biological Chemistry 277, 29210-29223.
119. SMITH, C. L., MITTAUD, P., PRESCOTT, E. D., FUHRER, C. & BURDEN, S. J. (2001) Src, Fyn, and Yes are not required for neuromuscular synapse formation but are necessary for stabilization of agrin-induced clusters of acetylcholine receptors. Journal of Neuroscience 21, 3151-3160.
120. THOMSEN, R. H. & WILSON, D. F. (1983) Effect of 4-aminopyridine and 3,4-diaminopyridineon transmitter release at the neuromuscular junction. J. Pharmacol. Exp. Therap. 227, 260-265.
121. TSUJINO, A., MAERTENS, C., OHNO, K. et al. (2003) Myasthenic syndrome caused by mutation of the SCN4A sodium channel. Proc. Natl. Acad. Sci. USA 100, 7377-7382.
122. UCHITEL, O., ENGEL, A. G., WALLS, T. J., NAGEL, A., ATASSI, Z. M. & BRIL, V. (1993) Congenital myasthenic syndromes. II. A syndrome attributed to abnormal interaction of acetylcholine with its receptor. Muscle and Nerve 16, 1293-1301.
123. VINCENT, A., NEWSOM-DAVIS, J., WRAY, D. et al. (1993) Clinical and experimental observations in patients with congenital myasthenic syndromes. Ann. N. Y. Acad. Sci. 681, 451-460.
124. WALLS, T. J., ENGEL, A. G., NAGEL, A. S., HARPER, C. M. & TRASTEK, V. F. (1993) Congenital myasthenic syndrome associated with paucity of synaptic vesicles and reduced quantal release. Ann. N. Y. Acad. Sci. 681, 461-468.
125. WANG, H.-L., AUERBACH, A., BREN, N., OHNO, K., ENGEL, A. G. & SINE, S. M. (1997) Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation. Journal of General Physiology 109, 757-766.
126. WANG, H.-L., MILONE, M., OHNO, K. et al. (1999) Acetylcholine receptor M3 domain: Stereochemical and volume contributions to channel gating. Nature Neurosci. 2, 226-233.
127. WANG, H.-L., OHNO, K., MILONE, M. et al. (2000) Fundamental gating mechanism of nicotinic receptor channel revealed by mutation causing a congenital myasthenic syndrome. Journal of General Physiology 116, 449-460.
128. WILLMAN, R. & FUHRER, C. (2002) Neuromuscular synaptogenesis. Cell. Mol. Life Sci. 59, 1296-1316.
129. WITZEMANN, V., SCHWARTZ, H., KOENEN, M. et al. (1996) Acetylcholine receptor epsilon subunit deletion causes muscle weakness and atrophy in juvenile and adult mice. Proceedings of the National Academy of Sciences of the United States of America 93, 13286-13291.
130. WOOD, S. J. & SLATER, C. P. (2001) Safety factor at the neuromuscular junction. Progresse in Neurobiology 64, 393-429.
131. YUN, K. & WOLD, B. (1996) Skeletal muscle determination and differentiation: Story of a core regulatory network and its content. Curr. Opin. Cell Biol. 8, 877-889.
132. ZHONG, W., GALLIVAN, J. P., ZHANG, Y., LI, L., LESTER, H. A. & DOUGHERTY, D. A. (1998) From ab initio quantum mechanics to molecular neurobiology: A cation-π binding site in the nicotinic receptor. Proc. Natl. Acad. Sci. USA 95, 12088-12093.